Xiaflex 0.9 MG vials
Ended Awarded
- Contract number
- SPE2DB25FYX53
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,682
Award facts
- Contract value 100% obligated
- $24,681.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,681.72 by the Defense Logistics Agency for the supply of Xiaflex 0.9 mg vials. The contract is firm fixed-price with an ultimate completion date of September 25, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026.
The Indefinite Delivery Contract enables the Defense Logistics Agency to issue delivery orders for a comprehensive range of pharmaceutical products to support medical supply needs across military health facilities nationwide. DMS Pharmaceutical Group's portfolio includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables spanning multiple product categories. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. Xiaflex, a collagenase product used in medical treatment, represents one of the specialized pharmaceutical items within the contractor's extensive federal contract portfolio.
Quick answers
Who was awarded contract SPE2DB25FYX53?
SPE2DB25FYX53 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FYX53 worth?
The government has obligated $24,682 on SPE2DB25FYX53.
Is contract SPE2DB25FYX53 an order under another contract?
Yes. SPE2DB25FYX53 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX53 competed?
The extent of competition for SPE2DB25FYX53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award